Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. [electronic resource]
Producer: 20010906Description: 1172-80 p. digitalISSN:- 0360-3016
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- California -- epidemiology
- Carcinoma, Squamous Cell -- drug therapy
- Chemotherapy, Adjuvant -- adverse effects
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Hemoglobins -- analysis
- Humans
- Laryngeal Neoplasms -- drug therapy
- Laryngectomy -- adverse effects
- Life Tables
- Male
- Middle Aged
- Neoplasm Staging
- Neoplasms, Second Primary -- epidemiology
- Radiotherapy, Adjuvant -- adverse effects
- Remission Induction
- Retrospective Studies
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.